Byterna Therapeutics
Contact Us
← All news & publications

OCT 2023 · FINANCING

Seed financing completed

The financing supported the development of an AI-powered circular mRNA drug discovery platform.

BYTERNA / FINANCING MILESTONE

STRATEGIC MOMENTUM FOR RNA MEDICINES

Seedfinancing completed.

OUR INVESTOR

Seed round iconFounding team of a publicly listed companySeed investor

Byterna completed its seed financing round in October 2023, backed by the founding team of a publicly listed company.

The financing supported the development of an AI-powered circular mRNA drug discovery platform.